Is it legal to sell peptides in Florida?

Can I sell peptides in Florida?

There is no blanket answer to whether you can sell peptides in Florida. Florida's Chapter 499 defines a drug by tests such as recognition in a listed compendium, intended use for disease, or intended effect on body structure or function, and it requires a permit before operating for covered persons and establishments. Bring your exact product and activities to Florida's Division of Drugs, Devices and Cosmetics and qualified counsel. [1][5]

Under section 499.003, Florida defines "distribute" or "distribution" as to sell, purchase, trade, deliver, handle, store, or receive, and the term does not mean to administer or dispense. [28] The Florida Division of Drugs, Devices and Cosmetics says its drug permitting falls into two main categories: manufacturing and repackaging conducted in Florida, and distributing in and into Florida. [4]

Start with a written description of the article you plan to offer. A name or a label alone cannot settle its category. Florida's statutory definitions and federal intended use evidence raise different questions that need to be evaluated together. [1][3][22]

Then trace what your business and its partners actually do. Florida DDC describes permitting around manufacturing or repackaging in Florida and distribution in or into the state. A company name, website, or shipping address does not replace an activity map. [4]

Key Facts

• Florida defines a drug as an article recognized in listed pharmacopoeias, intended for diagnosis, cure, mitigation, treatment or prevention of disease, intended to affect the structure or any function of the body, or intended as a component of such an article, with a stated device exclusion. [1]
• Florida defines distribution as to sell, purchase, trade, deliver, handle, store, or receive. [28]
• Section 499.01 says a permit is required before operating for each person and establishment that intends to operate in its listed categories. [5]
• A prescription drug wholesale distributor permit is required for any person who is a wholesale distributor of prescription drugs and wholesale distributes them in Florida, and an out of state wholesale distributor engaging in wholesale distribution into Florida needs an out of state permit. [7][8]
• Section 499.012 says an establishment that is a place of residence may not receive a permit and may not operate under that part. [12]
• The Division of Drugs, Devices and Cosmetics says an interpretation of a statute or rule requires a Petition for Declaratory Statement, and that its FAQ responses are not an informal legal opinion. [14]
• Florida Revenue says a business that will sell taxable goods or services must register as a sales and use tax dealer before it begins conducting business in Florida. [17]
• In a warning letter, FDA stated that despite labeling reading "FOR RESEARCH USE ONLY" and "NOT INTENDED FOR HUMAN USE", website evidence established that the named seller's products were intended to be drugs for human use. [21]

TL;DR

Build a product dossier and a transaction map before asking which Florida permit may apply. Send unresolved classification and activity questions to DDC and Florida counsel. Handle Sunbiz and Florida Revenue questions on their own facts, then record what remains unresolved before launch.

Classify the product before choosing a Florida permit

Begin with the product's actual composition and intended use, because Florida's drug and prescription drug definitions determine which Chapter 499 questions to ask. [1][3] Do not assign a category from the word peptide alone.

Florida's definition of a drug has several branches. It covers an article recognized in specified compendia, an article intended for disease related use, an article intended to affect body structure or function, and an article intended as a component of those articles, subject to the stated device exclusion. The statutory language expressly includes active pharmaceutical ingredients within the component branch. Each branch asks for evidence about the particular article and how it is presented. [1] A seller who has not identified the article's composition, purpose, labeling and distribution context cannot complete that comparison responsibly.

The prescription drug definition requires a separate review. It addresses specified finished forms and active pharmaceutical ingredients under the provisions cited in that definition. For an active pharmaceutical ingredient, the statutory qualification asks whether substantially all finished forms in which it may lawfully be dispensed or administered in Florida are themselves prescription drugs. [3] Record the ingredient's identity and the exact form you propose to transfer, then ask counsel or DDC how that qualification applies. Do not infer that every peptide ingredient falls on the same side of it.

Use a product dossier with these fields: exact article identity; composition and supporting records; physical form and packaging; proposed label text; every product page and advertisement; descriptions supplied to business buyers; representations made by staff; intended recipient; and the basis for any proposed statutory category. Keep a copy of each version with its date. The form is useful because federal intended use can be shown by expressions, design, composition, distribution circumstances, labeling, advertising and other statements by responsible persons. [22] A later change in a product page or sales script can change the evidence you need to evaluate.

For the general intended-use and research label framework, see Peptide state business licensing; this page starts with a Florida product dossier. FDA has warned a specific seller that research only label wording did not negate contrary website evidence of intended drug use. 21] For warning letter patterns, see [What FDA warning letters say about peptide marketing. That example shows why you should collect actual marketing evidence and obtain a product specific review. It does not establish a classification for your article.

Leave a blank in the dossier where evidence is missing. Write the unanswered question beside the missing item, such as whether the proposed article meets a statutory branch or whether its form changes the prescription drug analysis. Do not turn uncertainty into a category by changing a label. The classification review is the input to the activity and permit questions below, not an outcome those later questions can supply.

Map each seller activity and physical handoff

Map each actor's selling, purchasing, trading, delivery, handling, storage and receipt before asking DDC which activity category fits. The current Florida statute uses those activities to define distribution. [28] DDC's FAQ uses additional offer and title or physical transfer language; its own disclaimer says FAQ responses are not legal opinions or agency policy. Record that wording separately and ask DDC or Florida counsel to resolve its relevance to your facts. [2][14]

Draw a separate row for every actor. Your rows may include your company, a product manufacturer, a contract packager, a warehouse, a site operator, a payment recipient, a carrier and a buyer. Identify who owns the goods at each point, who has physical custody, who makes the offer, who accepts an order and who directs the next transfer. Do not use one broad label such as supplier to cover several legal persons. The point of this map is to make the facts visible to the reviewer, not to assign a permit by analogy.

For example, imagine a hypothetical Florida company that posts a product listing while another company holds the goods. Mark the website operator, any seller, the title holder and the custodian in separate columns. Ask which party actually sells, delivers, handles, stores or receives the article under the current statutory definition. [28] Record the FAQ's offer language as a separate question for DDC or Florida counsel, rather than treating the listing alone as a statutory distribution finding. [2][14] The map does not decide whether that company's product is a drug or whether a particular permit applies.

In another hypothetical, a Florida warehouse receives cartons, keeps them on a shelf and sends them on instruction from a different company. Record who contracted with the warehouse, who owns the goods, who chooses the recipient and who directs disposition. These facts may matter to the logistics category if the article is a covered prescription drug and the other statutory conditions are met. [11] A warehouse address by itself cannot answer that conditional question.

Add a physical route beneath the actor rows. Show the origin premises, any processing premises, storage locations, the place where title changes, and the final recipient. Mark whether each location is in Florida or elsewhere. Florida DDC describes its drug permit concerns as manufacturing or repackaging conducted in Florida and distribution in or into Florida. [4] That description makes location important even when the website and the staff are elsewhere.

A useful handoff record has columns for actor, action, location, title before and after, possession before and after, recipient type, document proving the event, and unresolved DDC question. Attach the proposed purchase terms, invoices, fulfillment agreement and shipping instructions as evidence if they exist. If they do not yet exist, mark them as planned, not completed. An accurate planned route lets counsel review the intended activity without pretending it has already happened.

Keep a separate map for each route because recipient and transfer facts can differ even when the product is identical.

Match the Chapter 499 permit categories to the facts

Compare your documented activity with the Chapter 499 permit categories, then ask DDC which category applies to each covered person and establishment. The statute says a permit is required before operating for each person and establishment that intends to operate in its enumerated categories. [5]

Use the following conditional table as an inquiry guide. Every row assumes that the product classification and the described activity have first been established. It does not say a listed category covers every peptide transaction.

The manufacturer row comes from a statutory requirement for a manufacturer of a prescription drug that manufactures or distributes those prescription drugs in Florida. [6] The wholesale row concerns a person who is a wholesale distributor of prescription drugs and wholesale distributes them in the state. [7] These descriptions make the seller's role and product category critical. They are not interchangeable names for a general ecommerce seller.

For the over the counter row, the statute addresses persons engaged in manufacture or repackaging of an over the counter drug. [10] Record what processing takes place, who performs it and where before relying on that row. For the logistics row, the statute describes a contractual service on behalf of a manufacturer, wholesale distributor or dispenser, with no title and no responsibility to direct sale or disposition. [11] Do not call a company a logistics provider merely because it ships boxes.

Add an unresolved branch if your facts do not fit these examples. The DDC application menu shows further categories and an exemption letter route, but their presence on the menu does not establish that an exemption applies. [13] Ask DDC to identify the correct application path on your submitted facts. If several entities or establishments perform covered activities, ask about each one; the statutory opening language refers to each person and establishment. [5]

For the broader state and local licensing framework, see Peptide state business licensing; this page applies Florida Chapter 499 to documented facts.

Put the reviewed product classification beside each candidate branch so the category inquiry follows the evidence.

Separate Florida wholesale and inbound distribution branches

The wholesale question turns on the recipient, the prescription drug classification and the direction of distribution. Florida defines wholesale distribution around distribution or receipt of a prescription drug by a person other than a consumer or patient, subject to enumerated exceptions. [9]

Build one transaction sheet for a hypothetical in state route: a Florida business transfers a reviewed prescription drug to a Florida business recipient. Record the recipient's identity and role, the transfer documents, the location of each party and whether any listed statutory exception needs review. If the facts establish wholesale distribution in Florida, the cited permit provision addresses a prescription drug wholesale distributor operating there. [7] That conditional statement is narrower than saying every sale to a business is wholesale or that every business buyer creates a permit duty.

Build a second sheet for a hypothetical route from a distributor located outside Florida but within the United States or its territories into Florida. The out of state wholesale provision addresses a wholesale distributor of prescription drugs in that location pattern. It also requires the distributor to maintain a license or permit compliant with the law of its resident state. Where that state does not require a wholesale distribution license, the quoted provision calls for a license as required by the federal act. [8] Record the origin state, the actual resident entity and its credentials; do not substitute a Florida mailing address for those facts.

Now compare a proposed transfer to a consumer with a proposed transfer to a business. Recipient status is one component of the statutory wholesale definition, which also introduces enumerated exceptions. [9] Put a specific exception question in the DDC or counsel inquiry instead of treating the opening clause as a complete legal test.

Your comparison sheet should have separate columns for origin, destination, article classification, transferor, recipient, recipient status, title event, physical event, proposed statutory branch, home jurisdiction credential and unresolved exception. This format makes two common confusions visible. First, an in state distributor and an out of state distributor have differently described permit provisions. [7][8] Second, a customer delivery and a wholesale transfer should not be merged without checking the statutory recipient language. [9]

Give DDC the paired transaction sheets so its response can address the route actually planned, including the inbound branch. [8]

For a multi state licensing overview, see Peptide state business licensing; the inbound Florida branch here is narrower. Keep any other state's requirements on a separate sheet. This Florida analysis concerns the cited Florida definitions and permit text, not a prediction about another jurisdiction.

For the general online sale framework beyond this Florida route, see Is it legal to sell peptides online?.

Test manufacturing, repackaging and premises before an application

Identify every processing step and every premises before completing a Florida application. DDC describes one major permitting branch as Florida manufacturing or repackaging, while Chapter 499 has specific manufacturer and logistics provisions that turn on actual operations. [4][6][10][11]

Write the process as a sequence from receipt to outbound shipment. At each step, record whether an actor makes, fills, combines, packages, labels, changes packaging, stores, or dispatches the article. These verbs are prompts for fact gathering, not a claim that each verb has the same legal meaning. Name the person who performs the step, the company responsible under its contract and the physical address. If an outside contractor performs a step, attach the agreement and show whose inventory is involved. DDC can then evaluate the correct category without inferring operations from a generic vendor description.

A hypothetical company might buy sealed stock and send it unchanged to a warehouse. A different hypothetical company might direct another facility to change packaging before distribution. Those process maps are materially different because the cited over the counter manufacturer provision expressly mentions manufacture or repackaging, and the prescription drug manufacturer provision refers to manufacture or distribution by the manufacturer. [6][10] Neither hypothetical resolves the article's classification or tells you which permit will issue. The purpose is to make the branch review possible.

For each premises, make a record with its address, owner or operator, activities, inventory held, incoming and outgoing routes, and the document that supports the description. Include storage points controlled by another party. The logistics provision describes a contractor handling warehousing, distribution or related services for specified principals while lacking title and direction responsibility. [11] Record those contractual facts rather than assuming a warehouse fits the category because it receives shipments.

Florida's cited establishment provision says a place of residence may not receive a permit and may not operate under that part. [12] If any proposed establishment is a residence, flag it for immediate review before treating it as an application address. Do not relabel the same place in your plan to escape the question. Ask DDC and Florida counsel which establishment and statutory part your activities would fall under, using the real address and real operations.

Keep premises evidence distinct from business formation. A filed company can still have an unresolved facility question. A lease or warehouse contract can identify a location without classifying the product or establishing a permit category. The processing file should travel with the product dossier and actor map so a reviewer can see who does what and where. Revise the permit inquiry if a contract changes the activity before operations change. For the general operating compliance framework, see Peptide state business licensing; this page uses Florida DDC and Revenue records for its launch file.

Prepare the Florida DDC permit inquiry and application file

Prepare one fact packet that lets DDC or Florida counsel evaluate the product, each actor, each establishment and each proposed route. DDC's published application menu is a navigation aid for possible categories; it is not an approval of your product or business plan. [13]

Copy this Florida DDC inquiry template for each proposed product and transaction route. Complete the blanks with documented facts or write “unconfirmed”; attach the named records and version dates. A proposed application category is a question for review, not a conclusion. [5][13]

For a warehouse question, attach the contract and ask whether the documented principal, title and disposition rights meet the cited logistics conditions. [11] Mark an unsigned contract or unselected premises as proposed. Keep a separate completed template for each materially different route so the response identifies the facts it addresses.

The DDC application page lists prescription drug wholesale distributor, out of state wholesale distributor, manufacturer, repackager and exemption letter routes, among others. [13] Record the route you are considering and why, but do not treat a form's availability as proof of eligibility. Ask whether another route or additional person or establishment must be evaluated under Chapter 499's before operating language. [5] Keep the agency's written response with the version of the facts it addressed.

If you later change the article, the manufacturing steps, the warehouse, the transfer of title or the destination, update the packet. A response to one fact pattern should not silently migrate to another. Give counsel a short change log so they can identify which prior analysis still applies. This approach turns a vague question about whether you can sell peptides into a bounded request about a named article and transaction. It also keeps an application separate from a decision to start operating. The guide Can you legally sell peptides in the UK? covers this in more detail.

Form the business without confusing its name with a drug permit

Use Sunbiz to establish the Florida business identity, then evaluate any fictitious name separately from the DDC activity question. Sunbiz lists routes for corporations, limited liability companies and partnerships, while its fictitious name page describes registration for a person using a fictitious or DBA name before conducting business in Florida. [15][16]

Choose the entity record by asking who will own assets, sign contracts and appear in the actor map. Sunbiz presents formation routes for a profit or nonprofit corporation, a limited liability company and a partnership. [15] Record the entity's exact legal name and the filing evidence once it exists. The name must match the person identified in agreements and in any DDC inquiry. If a partner, warehouse operator or related company is a different legal person, put that person on a separate row rather than hiding it under your brand.

Use a simple identity table:

The rows must not be substituted for one another. A registered trade name identifies how a person does business under the cited Sunbiz rule; the Chapter 499 question asks about product and activity. [5][16] A filed company may have a valid identity record while its product classification remains open. A proposed brand may be ready for use while the person that will make the offer has not been identified in the transaction documents.

For a hypothetical shop called Bay Lab Supply operated by a different legal entity, write both names in the map and say which one signs each agreement. This example is only a naming exercise; it gives no assurance that either the name or the activity is accepted. If the trade name changes after the documents are drafted, revise the actor map and the DDC packet so that the recipient sees the same legal person across records.

Check the exact Sunbiz route for the structure you select. If a fictitious name is planned, compare the proposal with Sunbiz's stated requirement and obtain advice on any uncertain applicability. 15][16] For broader launch steps outside these Florida identity questions, see [How to start a peptide ecommerce business. Keep this section focused on who your business is, leaving product and permit review to the preceding Florida record.

Resolve Florida sales tax registration by transaction type

Ask Florida Revenue about the tax treatment of your actual article and sales routes before deciding which registration applies. Revenue says a business that will sell taxable goods or services must register as a sales and use tax dealer before conducting business in Florida. [17] Leave your proposed article's taxability open for review.

Copy the Florida Revenue worksheet below and complete one row per transaction type. Write “unconfirmed” for taxability until Revenue or qualified tax counsel reviews the actual article. A proposed Chapter 499 category does not answer the separate tax question. [17][18]

Revenue's online Florida Business Tax Application uses an interactive wizard to determine registration requirements. [18] Before opening it, gather the legal entity name, business locations, planned taxable activities and sales channels. Revenue also states that businesses must register each location to collect, report and pay sales tax. [19] Give the wizard or Revenue the actual locations from your premises file. Do not replace several operating locations with the registered agent's address without asking how the rule applies.

Keep direct and facilitated sales on separate rows. Revenue's taxable goods instruction raises a seller registration question for a direct sale; its marketplace rule raises a distinct question for facilitated Florida deliveries. [17][27] Attach the invoice model, location list and taxability response to the relevant row.

For a business making remote sales into Florida, Revenue's stated rule concerns taxable remote sales in excess of $100,000 over the previous calendar year and calls for collecting and electronically remitting tax on the specified transactions. [20] Record the prior calendar year's taxable remote sales and ask Revenue whether your business fits the rule. This threshold is not a general license to sell below a number, a product classification test or an answer to a Florida location question. Its exact comparison words matter: the quoted page says in excess of, not at or above. [20]

Keep Revenue's answer and the completed registration evidence beside, but separate from, the DDC packet. A tax registration does not evaluate an article under Chapter 499. A DDC response does not decide taxability. Record the owner of each unanswered question and the point in the launch plan where the answer is needed. That separation keeps a completed form from being mistaken for a complete commercial authorization.

For the broader tax workflow, see Peptide business taxes; this worksheet is limited to the Florida Revenue questions above.

Use Florida’s formal interpretation route for unresolved facts

If the statutory fit remains uncertain after you have assembled the facts, ask DDC or Florida counsel through a question that identifies the exact rule and transaction. DDC says obtaining an agency interpretation of a statute or rule requires a Petition for Declaratory Statement authorized by Chapter 120, and its FAQ responses are not legal opinions or agency policy. [14]

Create a question log before contacting anyone. Each line should state one issue, the factual premise, the cited section or DDC page, the supporting attachment, the person assigned to seek an answer and the current state of that answer. Separate “Which product category applies?” from “Which person needs a permit?” and “Which establishment needs review?” They may have different evidence and should not be answered by a single general statement. Use the statutory language that actually bears on each question rather than a marketplace description of the product.

For example, a hypothetical warehouse arrangement may leave title with the principal while the contract gives the warehouse some decision rights over destination. The logistics provision specifies no title and no responsibility to direct sale or disposition. [11] The log should name the disputed contract clause and ask how it affects that provision. A second line may ask whether another listed permit category fits the same facts. This framing helps the authority or counsel see the issue without suggesting a result.

Track what kind of response you receive. A DDC FAQ can help locate a topic, but the FAQ itself warns that its answers are not legal opinions or agency policy and identifies the declaratory statement route for an interpretation. [14] Keep informal navigation, professional advice, a filed petition and any resulting written agency record in distinct fields. Do not label a phone conversation or a general web page as a determination on your business.

Add a source register beside the log. Record the statute section and edition, the URL, the date you accessed it, the quoted clause and any version of a DDC page used. The supplied statutory excerpts are from the Florida Senate's 2026 chapter pages as accessed on October 5, 2026. [1][5] Recheck the applicable text before action and whenever the business facts change.

Keep the question log open until a response addresses the submitted facts. Copy any conditions into the launch register, and attach requested product, contract or premises evidence. For the general state compliance program, see Peptide state business licensing; this page uses a Florida DDC question log.

Record a launch decision with explicit pause conditions

Make a launch decision only from a register that shows each distinct question, its evidence and its reviewer. Chapter 499's before operating permit language, Revenue's taxable sales registration instruction and federal intended use and advertising evidence make different demands on your file. [5][17][22][23]

Copy this launch decision register and fill every applicable row for each proposed route. Enter “unknown” where evidence is missing. Record a dated reviewer response and its conditions before changing a row to complete.

Define pause conditions before spending on irreversible commercial commitments. Pause the hypothetical launch if the product classification remains unsupported, if the operating person or establishment has an unresolved Chapter 499 permit question, or if taxable sales registration has not been determined for the actual route. These are decision rules for your internal plan, not a claim that any statute uses the phrase pause. The cited Chapter 499 language requires covered persons and establishments to obtain a permit before operating, while Revenue states its registration timing for sellers of taxable goods or services. [5][17]

Run a worked hypothetical. Suppose you have a proposed article, a Florida website operator, an out of state warehouse and a proposed Florida business buyer. Your map shows a proposed listing, a custody handoff and a business recipient; identify which actors sell, handle, store, receive or deliver under the current statutory wording. [28] The product dossier does not yet establish whether the article is a prescription drug under the relevant definition. [3] Mark the product row unknown, the wholesale branch pending the classification and statutory exceptions, and the warehouse contract awaiting review of title and direction. [9][11] The register calls for review before a launch decision. It does not imply that these facts require or avoid a specific permit.

Review marketing separately. Federal intended use can be evidenced by expressions, design, composition, distribution circumstances and advertising. [22] FTC guidance says advertising should be truthful and not misleading and objective claims need adequate substantiation before dissemination. [23] Put the actual proposed public copy into the register and ask the appropriate reviewer whether it matches the product dossier. Do not record a clean marketing row merely because the label has a research purpose statement.

At the decision meeting, require a document reference for every completed row and a named person for each open one. Record the exact transaction routes that were reviewed. If the business changes its article, premises, contract or sale channel, reopen the affected rows. This gives you a traceable reason to proceed or hold a specific route without claiming a universal legality result for peptides in Florida.

What to do next

1. Write a product dossier with composition, presentation, intended use evidence and explicit unresolved Florida classification questions. [1][3][22]

2. Map each seller, manufacturer, warehouse, title transfer, recipient and physical establishment for every planned route. [28][4]

3. Compare that map with the cited Chapter 499 categories and mark unmatched or exception dependent branches unresolved. [5][9]

4. Prepare the Florida DDC inquiry packet and obtain category specific professional or agency review. [13][14]

5. Check facility facts and ask about any residence proposed as an establishment under the cited part. [12]

6. Choose Sunbiz entity and, if applicable, fictitious name registration routes separately from the DDC question. [15][16]

7. Use Florida Revenue's registration wizard with actual taxable product, location, direct sale and marketplace facts. [17][18][19]

8. Record evidence, a responsible reviewer and pause conditions before taking an irreversible commercial step. [5][17]

When should you book a peptide business fit call?

Book a peptide business fit call once you can bring a product dossier, an actor map and a list of unresolved DDC, Sunbiz and Revenue questions. The discussion can help organize those facts and the next review steps. It cannot replace a Florida agency determination or qualified legal and tax advice.

Frequently Asked Questions

Can I sell peptides in Florida?

There is no blanket answer, because Chapter 499 turns on whether the article is a drug under its definition and on what distribution activity you carry out, and it requires a permit before operating for covered persons and establishments. [1][5][28]

Do I need a license to sell peptides in Florida?

Section 499.01 requires a permit before operating for each person and establishment that intends to operate in its listed categories, so whether you need one depends on the category your product and activity fall into. [5] The Division publishes category specific permit application pages. [13]

Can I sell peptides from home in Florida?

Section 499.012 says an establishment that is a place of residence may not receive a permit and may not operate under that part. [12]

Does research use only labeling let me sell peptides in Florida?

Not by itself, because FDA has stated that research use only labeling did not negate website evidence that a seller's products were intended to be drugs for human use. [21] 21 CFR 201.128 says intent may be shown by expressions, design or composition, and the circumstances surrounding distribution. [22]

What counts as distributing a drug in Florida?

Florida defines distribution as to sell, purchase, trade, deliver, handle, store, or receive, and the term does not mean to administer or dispense. [28]

Do I need to register for Florida sales tax to sell peptides online?

Florida Revenue says that if your business will sell taxable goods or services you must register as a sales and use tax dealer before you begin conducting business in Florida. [17] Florida law requires businesses making taxable remote sales into the state to collect and remit tax if they made taxable remote sales in excess of $100,000 over the previous calendar year. [20]

How can I check whether a Florida seller has a drug permit?

The Division of Drugs, Devices and Cosmetics public records list permit type, permit status, permit number, first permit date, renewal date and expiration date. [24]

Can the Florida DDC tell me whether my peptide needs a permit?

The Division says an agency cannot provide an informal legal opinion, and that obtaining an interpretation of a statute or rule requires a Petition for Declaratory Statement. [14] A menu entry or FAQ is not a ruling on your facts.

Sources

These are the Florida and federal primary sources supporting the cited points, accessed on October 5, 2026.

1. The Florida Senate, 2026 Florida Statutes section 499.003, accessed 2026-10-05.

2. Florida Department of Business and Professional Regulation, Division of Drugs, Devices and Cosmetics, Frequently Asked Questions, accessed 2026-10-05.

3. The Florida Senate, 2026 Florida Statutes section 499.003, accessed 2026-10-05.

4. Florida Department of Business and Professional Regulation, Division of Drugs, Devices and Cosmetics, Frequently Asked Questions, https://www2.myfloridalicense.com/drugs-devices-and-cosmetics/faqs/, accessed 2026-10-05.

5. The Florida Senate, 2026 Florida Statutes section 499.01, accessed 2026-10-05.

6. The Florida Senate, 2026 Florida Statutes section 499.01, accessed 2026-10-05.

7. The Florida Senate, 2026 Florida Statutes section 499.01, accessed 2026-10-05.

8. The Florida Senate, 2026 Florida Statutes section 499.01, accessed 2026-10-05.

9. The Florida Senate, 2026 Florida Statutes section 499.003, accessed 2026-10-05.

10. The Florida Senate, 2026 Florida Statutes section 499.01, accessed 2026-10-05.

11. The Florida Senate, 2026 Florida Statutes section 499.01, accessed 2026-10-05.

12. The Florida Senate, 2026 Florida Statutes section 499.012, accessed 2026-10-05.

13. Florida Department of Business and Professional Regulation, Division of Drugs, Devices and Cosmetics, Apply for a Permit, accessed 2026-10-05.

14. Florida Department of Business and Professional Regulation, Division of Drugs, Devices and Cosmetics, Frequently Asked Questions, accessed 2026-10-05.

15. Florida Department of State, Division of Corporations, Start a Business, accessed 2026-10-05.

16. Florida Department of State, Division of Corporations, Fictitious Name Registration, accessed 2026-10-05.

17. Florida Department of Revenue, Florida Business Tax Application, accessed 2026-10-05.

18. Florida Department of Revenue, Florida Business Tax Application, accessed 2026-10-05.

19. Florida Department of Revenue, Sales and Use Tax, accessed 2026-10-05.

20. Florida Department of Revenue, Sales and Use Tax, accessed 2026-10-05.

21. U.S. Food and Drug Administration, Warning Letter to Xcel Research LLC, accessed 2026-10-05.

22. Electronic Code of Federal Regulations, 21 CFR 201.128, accessed 2026-10-05.

23. Federal Trade Commission, Health Products Compliance Guidance, accessed 2026-10-05.

24. Florida Department of Business and Professional Regulation, Division of Drugs, Devices and Cosmetics, Public Records, accessed 2026-10-05.

25. Florida Department of Revenue, Sales and Use Tax, accessed 2026-10-05.

26. Florida Department of Revenue, Sales and Use Tax, accessed 2026-10-05.

27. Florida Department of Revenue, Sales and Use Tax, accessed 2026-10-05.

28. The Florida Senate, 2026 Florida Statutes section 499.003(16), accessed 2026-10-05.

Educational and legal disclaimer

This article provides educational information about planning questions and cited public sources. It is not legal, regulatory, tax, banking, medical, product, import, export, platform or payment advice. The facts of your product, business, transaction and location need individual review by the relevant Florida authority and qualified professionals. No statement here predicts a permit, registration, listing, account or shipment decision.